Evidence map›Paper›PMID 38694943›Full record

ArticleFrontiers in endocrinology2024

Decreasing lifetime prevalence of diabetes-related foot ulcers in Norway: repeated cross-sectional population-based surveys from the HUNT study (1995-2019).

Hilde K R Riise, Jannicke Igland, Marit Graue, Anne Haugstvedt, Truls Østbye, Eirik Søfteland, Monica Hermann, Sofia Carlsson, Bjørn Olav Åsvold, Marjolein M Iversen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Hilde K R RiiseDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Jannicke IglandDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Marit GraueDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Anne HaugstvedtDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Truls ØstbyeDepartment of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC, United States.
Eirik SøftelandDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Monica HermannDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Sofia CarlssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Bjørn Olav ÅsvoldHUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Marjolein M IversenDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Western Norway University of Applied Sciences · NODuke University · USHaukeland University Hospital · NOKarolinska Institutet · SENorwegian University of Science and Technology · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Diabetes-related foot ulcers (DFU) are a persistent healthcare challenge, impacting both patients and healthcare systems, with adverse effects on quality of life and productivity. Our primary aim was to examine the trends in lifetime prevalence of DFU, as well as other micro- and macrovascular complications in the Trøndelag Health Study (HUNT) in Norway. Methods: This study consists of individuals ≥20 years with diabetes participating in the population-based cross-sectional HUNT surveys (1995-2019). Prevalence ratios, comparing the lifetime prevalence of DFU and other relevant micro- and macrovascular complications between the HUNT surveys, were calculated using Poisson regression. Results: The lifetime prevalence (95% confidence interval (CI)) of a DFU requiring three or more weeks to heal was 11.0% (9.5-12.7) in HUNT2, 7.5% (6.3-8.8) in HUNT3 and 5.3% (4.4-6.3) in HUNT4. The decrease in DFU prevalence from 1995 to 2019 was observed in both men and women, for all age groups, and for both type 1 and type 2 diabetes. The highest lifetime prevalence of DFU was found among those with type 1 diabetes. The decrease in HbA1c from HUNT2 to HUNT4 did not differ between those with and without a DFU. The prevalence of chronic kidney disease (eGFR <60 mL/min/1.73 m Conclusion: Results from the HUNT surveys show a substantial decline in the lifetime prevalence of DFU from 1995 to 2019.

Indexed as

Diabetic FootAdultAgedAged, 80 and overCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedNorwayPrevalenceYoung Adultdiabetes complicationsdiabetes-related foot ulcerlifetime prevalenceprevalencetype 2 diabetes

Identifiers

PMID38694943
PMCPMC11061349
OpenAlexW4394888080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.